Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Clobetasol propionate is a super-high-potency topical corticosteroid prescribed for short-term relief of inflammation, redness, itching, and scaling from conditions such as plaque psoriasis, severe eczema, lichen planus, lichen sclerosus, and discoid lupus lesions. It is typically applied in a thin layer once or twice daily for no longer than two consecutive weeks, with total use usually capped around 50 grams per week, because prolonged application can cause skin thinning, stretch marks, and suppression of the body's own cortisol production. Duration limits, safe application sites, and tapering plans vary by diagnosis, age, and body area, so there are several important details to consider below before starting or continuing treatment.
If your rash, itching, or scaling is not improving, or you are unsure whether a potent steroid is the right fit for your symptoms, a fast and free symptom check can help you organize what you are experiencing and see which conditions may explain it. Taking a few minutes now can help you arrive at your appointment with clearer information, ask better questions, and avoid unnecessary weeks of using a medication that may not match your underlying problem.
Last reviewed for medical accuracy: 09/28/2026
Clobetasol propionate cream is a super-high-potency topical corticosteroid prescribed to reduce inflammation, itching, and redness in various skin conditions. Understanding what clobetasol propionate cream is used for, how it works, and how long you can safely use it helps you manage treatment effectively and avoid potential side effects.
Clobetasol propionate cream is mainly used to treat:
Clobetasol propionate cream works through three main actions:
These effects help break the cycle of inflammation and itching that worsen many chronic skin conditions.
Follow your doctor’s directions carefully. Here are general guidelines:
Because of its high potency, clobetasol propionate cream should be used for the shortest duration necessary to control symptoms.
Always follow your prescriber’s instructions. If your symptoms persist beyond the recommended duration, speak to your doctor for reevaluation.
While many patients tolerate clobetasol propionate cream well, potential side effects can occur, especially with prolonged or excessive use.
Preventing side effects
Before starting clobetasol propionate cream, consider the following:
Always inform your doctor of any other skin treatments, supplements, or health conditions before using clobetasol propionate cream.
Regular follow-up helps ensure safety and effectiveness:
Not sure if clobetasol propionate cream is right for your symptoms? You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can guide you on whether you need medical attention and suggest next steps.
free, online symptom check, using the doctor approved Ubie Symptom Checker
While most side effects are mild, some signs require prompt evaluation:
If you experience any potentially life-threatening or serious symptoms, speak to a doctor or seek emergency care right away.
Clobetasol propionate cream is a very potent topical steroid used to manage severe inflammatory skin conditions such as psoriasis, eczema, and lichen planus. Its powerful anti-inflammatory, immunosuppressive, and vasoconstrictive actions bring rapid relief, but require careful monitoring:
Always discuss any concerns—especially serious or life-threatening symptoms—with your healthcare provider.
(References)
* Fang JY, Shen KL, Huang YB, Wu PC, Tsai YH. Topical application of clobetasol 17-propionate from various cream bases by using Wistar rat as an animal model. Kaohsiung J Med Sci. 1998 May;14(5):286-93. PMID: 9619014.
* Abma EM, Blanken R, De Heide LJ. Cushing's syndrome caused by topical steroid therapy for psoriasis. Neth J Med. 2002 Apr;60(3):148-50. PMID: 12164372.
* Gen R, Akbay E, Sezer K. Cushing syndrome caused by topical corticosteroid: a case report. Am J Med Sci. 2007 Mar;333(3):173-4. doi: 10.1097/MAJ.0b013e3180318fbcx. PMID: 17496736.
* Verma KK, Rathi S, Pasricha JS. Failure of pentoxifylline to affect air- borne contact dermatitis caused by parthenium. Indian J Dermatol Venereol Leprol. 2000 May-Jun;66(3):129-31. PMID: 20877053.
* Schoepe S, Vonk R, Schäcke H, Zollner TM, Asadullah K, Röse L. Shortened treatment duration of glucocorticoid-induced skin atrophy in rats. Exp Dermatol. 2011 Oct;20(10):853-5. doi: 10.1111/j.1600-0625.2011.01341.x. Epub 2011 Aug 8. PMID: 21824195.
* Mitsuma A, Sawaki M, Shibata T, Morita S, Inada M, Shimokata T, Sugishita M, Kitagawa K, Sawada M, Nawa A, Ando Y. Extravasation of pegylated-liposomal doxorubicin: favorable outcome after immediate subcutaneous administration of corticosteroids. Nagoya J Med Sci. 2012 Feb;74(1-2):189-92. PMID: 22515126; PMCID: PMC4831265.
* Cleaver N, Ramirez J, Gildenberg S. Cutaneous lupus erythematosus in a patient undergoing intravitreal bevacizumab injections: case report and review of the literature. J Drugs Dermatol. 2013 Sep;12(9):1052-5. PMID: 24002156.
* Park JJ, Hawryluk EB, Tahan SR, Flaherty K, Kim CC. Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma. JAMA Dermatol. 2014 Mar;150(3):307-11. doi: 10.1001/jamadermatol.2013.7919. PMID: 24352115.
* Binois R, Nadal M, Esteve E, De Muret A, Kerdraon R, Gheit T, Tommasino M, Gaboriaud P, Touze A, Samimi M. Cutaneous Kaposi sarcoma during treatment with superpotent topical steroids and methotrexate for bullous pemphigoid: three cases. Eur J Dermatol. 2017 Aug 1;27(4):369-374. doi: 10.1684/ejd.2017.3027. PMID: 28659250.
* Sharma K, Parashar B, Wernicke AG. Cefadroxil-Induced Radiation Recall Dermatitis: A Case Report and Review of the Literature. Cureus. 2025 Jul;17(7):e88735. doi: 10.7759/cureus.88735. Epub 2025 Jul 25. PMID: 40717874; PMCID: PMC12296316.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.